Vendor evidence review

Active

Ion Peptide

Two selected Ion Peptide records reproduced on Freedom Diagnostics Testing's document host, and one selected ILS Laboratories record matched its verification packet. The records support batch-specific identity, purity, measured content, and additional testing statements, but not independent retail provenance or chain of custody.

An active storefront and batch-report library were observed on August 26, 2026. The site also displayed a notice allowing two to three extra processing days. These observations do not establish continuous fulfillment or future availability.

Last reviewed August 26, 2026Status checked August 26, 2026Evidence profile, not an endorsementScientific reviewer status pending

Answer in under 30 seconds

Quick verdict

Two selected Ion Peptide records reproduced on Freedom Diagnostics Testing's document host, and one selected ILS Laboratories record matched its verification packet. The records support batch-specific identity, purity, measured content, and additional testing statements, but not independent retail provenance or chain of custody.

A score summarizes only criterion outcomes backed by published evidence. Unknown and not-tested criteria are excluded, then shown in the coverage count.
Overall evidence85%10 of 12 criteria scored
COA transparency83%3 of 4 criteria scored
Testing evidence90%5 of 5 criteria scored

What we verified

  • Two selected Freedom Diagnostics records reproduced on the laboratory-controlled document host.
  • One selected ILS Laboratories report matched the vendor-hosted record and verification packet.
  • The selected records print lot identifiers and state identity, chromatographic purity, measured content, and batch-specific additional tests.

What we could not verify

  • Independent sample selection, retail provenance, or chain of custody.
  • Completeness of the report library or the site's every-batch statement.
  • That the reviewed ILS accreditation scope expressly covers the peptide panel shown.
  • Sterility across all three selected lots.

Major strengths

  • Multiple selected records are available through laboratory-controlled hosts or verification paths.
  • The reviewed documents preserve lot identifiers and separate analytical categories.
  • Recent records cover identity, purity, measured content, endotoxin, and selected additional tests.

Major concerns

  • PeptidesReview did not control sample selection or chain of custody.
  • PCR microbial results on the two Freedom reports are not sterility-test results.
  • The reviewed ILS scope does not expressly list the peptide panel shown on COA-2026-954643.

Criterion-level audit

Evidence scorecard

Every status remains visible so missing evidence cannot hide inside a composite percentage.

CriterionFindingProvenanceEvidence detail
Laboratory identity verificationVerifiedThird-party laboratory evidence

Two selected records reproduced on Freedom Diagnostics Testing's document host, and one selected record was tied to ILS Laboratories' verification packet.

Limitation: Laboratory identity does not establish that every printed method was within an accredited scope.
Report authenticityVerifiedThird-party laboratory evidence

Freedom accessions 2607150906 and 2606250581 reproduced on the laboratory host, and ILS COA-2026-954643 matched the selected vendor-hosted report and verification record.

Limitation: Authenticity applies to the selected documents, not the completeness of the vendor archive.
Batch or lot traceabilityPartially verifiedThird-party laboratory evidence

The selected reports and vendor library print lot identifiers, including NASK-07142026, CGL10-06252026, and 2S10-07152026.

Limitation: PeptidesReview did not match a purchased retail vial to the printed lots or observe chain of custody.
Peptide identity testingVerifiedThird-party laboratory evidence

The Freedom records state LC-MS identity results, and the ILS record states identity by HPLC retention-time matching.

Limitation: The findings apply only to the submitted samples and printed methods.
Purity testingVerifiedThird-party laboratory evidence

All three selected records state chromatographic purity results.

Limitation: Chromatographic purity does not establish quantity, sterility, safety, or future-lot performance.
Quantity testingVerifiedThird-party laboratory evidence

All three selected records state measured net content with units.

Limitation: Vendor-controlled submission does not establish ordinary retail provenance.
Sterility testingPartially verifiedThird-party laboratory evidence

The ILS packet states a sterility result for one selected submission. The two Freedom records state PCR microbial results, which were not treated as sterility tests.

Limitation: One selected sterility result does not establish sterility across every sampled or current lot. PCR microbial analysis is not equivalent to a compendial sterility test.
Endotoxin testingVerifiedThird-party laboratory evidence

All three selected records state batch-specific endotoxin results under the methods and thresholds printed in their report packets.

Limitation: These results apply only to the submitted samples and do not establish sterility or general safety.
Raw analytical data availabilityNot verifiedThird-party laboratory evidence

The public packet contains summary plots and report pages, but not raw files, integrations, calculations, or complete validation data.

Limitation: This finding is limited to the public material reviewed on 2026-08-26.
Testing recencyVerifiedThird-party laboratory evidence

The selected reports were issued from June 29 through July 31, 2026 and remained accessible on the review date.

Limitation: Recency does not establish future-lot performance.
Vendor transparencyPartially verifiedVendor-provided evidence

Ion Peptide provides a searchable report library, lot-specific documents, and links to selected laboratory records.

Limitation: The site's every-batch statement and archive completeness were not independently counted.
Independent purchase or testing evidenceNot verifiedOrigin not determined

PeptidesReview did not purchase, handle, or submit a sample and did not control chain of custody.

Limitation: The vendor or submitter controlled the tested samples.

Report authenticity

Verified

Freedom accessions 2607150906 and 2606250581 reproduced on the laboratory host, and ILS COA-2026-954643 matched the selected vendor-hosted report and verification record.

Batch or lot traceability

Partially verified

The selected reports and vendor library print lot identifiers, including NASK-07142026, CGL10-06252026, and 2S10-07152026.

Raw analytical data availability

Not verified

The public packet contains summary plots and report pages, but not raw files, integrations, calculations, or complete validation data.

Testing recency

Verified

The selected reports were issued from June 29 through July 31, 2026 and remained accessible on the review date.

Learn how to audit a peptide COA

Testing evidence

Reports tied to this vendor

A report is shown only when its source, scope, date, and limitations are recorded.

Third-party laboratory record

Ion Peptide SS-31 report COA-2026-954643

Laboratory
ILS Laboratories
Report date
2026-07-31
Batch or lot
2S10-07152026
Claimed quantity
10 mg
Measured quantity
10.36 mg mean across two samples
Chain of custody
notDocumented
Open the source report

Third-party laboratory record

Ion Peptide N-Acetyl Selank report 2607150906

Laboratory
Freedom Diagnostics Testing
Report date
2026-07-18
Batch or lot
NASK-07142026
Claimed quantity
10 mg
Measured quantity
9.57 mg average across three vials
Chain of custody
notDocumented
Open the source report

Third-party laboratory record

Ion Peptide Cagrilintide report 2606250581

Laboratory
Freedom Diagnostics Testing
Report date
2026-06-29
Batch or lot
CGL10-06252026
Claimed quantity
10 mg
Measured quantity
10.47 mg average across three vials
Chain of custody
notDocumented
Open the source report

Ion Peptide publishes a searchable report library, lot-oriented records, and links to selected laboratory documents. The reviewed sample does not establish complete archive coverage, independent sample selection, continuous fulfillment, or that every printed method falls within an accredited scope.

See how transparency evidence is evaluated

Comparable vendors

Continue with objective comparisons.

Final evidence-based assessment

The selected packet provides useful laboratory-side verification across two laboratories and three lots. The evidence supports the printed results for submitted samples, not a generalized conclusion about every product or lot. Retail provenance, chain of custody, complete archive coverage, manufacturing controls, safety, and future-lot performance remain outside what this review can establish.

Commercial relationship

PeptidesReview has no commercial relationship, affiliate arrangement, paid placement, or purchasing incentive involving Ion Peptide.

Right to reply

Ion Peptide was not contacted before publication. The profile will be corrected if documented evidence changes a material finding.

Sources and verification records

  1. Vendor-provided evidenceVendor-provided materialAccessed Aug 26, 2026
  2. Vendor-provided evidenceVendor-provided materialAccessed Aug 26, 2026
  3. ILS Laboratories SS-31 report for lot 2S10-07152026, ILS Laboratories, hosted by Ion Peptide
    Vendor-provided evidenceLaboratory documentReport or publication date Jul 31, 2026Accessed Aug 26, 2026
  4. Freedom report 2607150906, Freedom Diagnostics Testing
    Third-party laboratory evidenceLaboratory documentReport or publication date Jul 18, 2026Accessed Aug 26, 2026
  5. Freedom report 2606250581, Freedom Diagnostics Testing
    Third-party laboratory evidenceLaboratory documentReport or publication date Jun 29, 2026Accessed Aug 26, 2026
  6. ILS report COA-2026-954643, ILS Laboratories
    Third-party laboratory evidenceLaboratory documentReport or publication date Jul 31, 2026Accessed Aug 26, 2026
  7. ILS accreditation certificate L25-631 and scope, Perry Johnson Laboratory Accreditation
    Third-party laboratory evidenceAccreditation recordReport or publication date Aug 22, 2025Accessed Aug 26, 2026

PeptidesReview reproduced two selected Freedom Diagnostics records on the laboratory's document host and matched one selected ILS Laboratories record to its verification packet. The selected records include lot identifiers, identity, chromatographic purity, measured content, and additional batch-specific tests. Retail provenance, chain of custody, complete archive coverage, and accredited peptide-method scope remain unverified.

Vendor profile sources

  1. Vendor-provided evidenceVendor-provided materialAccessed Aug 26, 2026
  2. Vendor-provided evidenceVendor-provided materialAccessed Aug 26, 2026
  3. ILS Laboratories SS-31 report for lot 2S10-07152026, ILS Laboratories, hosted by Ion Peptide
    Vendor-provided evidenceLaboratory documentReport or publication date Jul 31, 2026Accessed Aug 26, 2026
  4. Freedom report 2607150906, Freedom Diagnostics Testing
    Third-party laboratory evidenceLaboratory documentReport or publication date Jul 18, 2026Accessed Aug 26, 2026
  5. Freedom report 2606250581, Freedom Diagnostics Testing
    Third-party laboratory evidenceLaboratory documentReport or publication date Jun 29, 2026Accessed Aug 26, 2026
  6. ILS report COA-2026-954643, ILS Laboratories
    Third-party laboratory evidenceLaboratory documentReport or publication date Jul 31, 2026Accessed Aug 26, 2026
  7. ILS accreditation certificate L25-631 and scope, Perry Johnson Laboratory Accreditation
    Third-party laboratory evidenceAccreditation recordReport or publication date Aug 22, 2025Accessed Aug 26, 2026

Read the complete methodology